Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2012
12/11/2012US8329168 Compositions and methods for modulating hemostasis
12/11/2012US8329167 EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases
12/11/2012US8329164 Methods and compositions concerning poxviruses and cancer
12/11/2012US8329160 Interferon alpha sequential regimen for treating cancers
12/11/2012US8329159 Hepatitis C virus inhibitors
12/11/2012US8329148 Photostabilization of coenzyme Q compounds with alkoxycrylene compounds
12/11/2012US8329144 Diagnostic and therapeutic epitope, and transgenic plant
12/11/2012US8328876 Bone matrix compositions and methods
12/11/2012CA2661042C Agents for blood-brain barrier delivery
12/11/2012CA2639048C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
12/11/2012CA2537544C Milk fractions and milk preparations for treating and/or preventing cox-2 mediated diseases
12/11/2012CA2524534C Methods and compositions for the prevention and treatment of sepsis
12/11/2012CA2513104C Survivin-derived peptides and use thereof
12/11/2012CA2507524C Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
12/11/2012CA2481479C Novel flavivirus antigens
12/11/2012CA2388054C Compositions and methods for stimulating an immune response against infectious agents
12/11/2012CA2284459C Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
12/11/2012CA2202519C Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase
12/09/2012CA2779710A1 F11 receptor (f11r) antagonists as therapeutic agents
12/06/2012WO2012167251A1 Long-acting glp-1/glucagon receptor agonists
12/06/2012WO2012167109A2 Rpgrip1 gene therapy for leber congenital amaurosis
12/06/2012WO2012167101A1 Ovarian cancer stem cells and methods of isolation and uses thereof
12/06/2012WO2012167077A1 Blockade of inflammatory proteases with theta - defensins
12/06/2012WO2012167028A2 Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition
12/06/2012WO2012166875A2 Modulating innate immune cell activity by lunasin and selected cytokines
12/06/2012WO2012166859A2 Modulation of sphingosine 1-phosphate metabolizing enzymes for the treatment of negative-strand rna virus infections
12/06/2012WO2012166810A1 Biologically active tri-peptide
12/06/2012WO2012166705A2 Supramolecular nanofibers and hydrogels based on amino acid-nucleobase-glycoside conjugates
12/06/2012WO2012166646A1 TARGETING p63 TO RE-ACTIVATE DORMANT RESERVE STEM CELLS IN OLFACTORY EPITHELIUM
12/06/2012WO2012166626A1 Reagents and methods for treating dental disease
12/06/2012WO2012166622A1 Therapeutic proteins with increased half-life and methods of preparing same
12/06/2012WO2012166611A2 Methods for treating and preventing neutrophil-derived net toxicity and thrombosis
12/06/2012WO2012166610A1 A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
12/06/2012WO2012166588A2 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
12/06/2012WO2012166554A2 Extracellular matrix material conduits and methods of making and using same
12/06/2012WO2012166158A1 Methods and compositions for the treatment of metabolic syndrome, obstructive respiratory disorders, cancer and related diseases
12/06/2012WO2012166006A1 Protein-polypeptide complex with a specific effect on skin tissue, method for producing said complex and pharmaceutical composition on the basis thereof
12/06/2012WO2012166005A1 Protein-polypeptide complex with a specific activity on skin tissue, process for preparing same and pharmaceutical composition on the basis thereof
12/06/2012WO2012166004A1 Protein-polypeptide complex with a specific activity on the nervous system, process for preparing same and pharmaceutical composition on the basis thereof
12/06/2012WO2012165953A1 Nanogels
12/06/2012WO2012165916A2 Non-peptidyl polymer-insulin multimer and method for producing the same
12/06/2012WO2012165915A2 Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate
12/06/2012WO2012165900A2 Peptide bfp 4 for promoting bone formation or vasculogenesis, and application therefor
12/06/2012WO2012165682A1 Bone forming peptide 4 for promoting osteogenesis or vascularization and use thereof
12/06/2012WO2012165345A1 Composition for preventing and/or ameliorating cancer-related irreversible metabolism disorders
12/06/2012WO2012165309A1 Composition for external use
12/06/2012WO2012164488A2 New cosmetic or dermopharmaceutical topical use of a mixture of a ghk tripeptide and gqpr tetrapeptide
12/06/2012WO2012164004A1 Novel antigen peptide and uses thereof
12/06/2012WO2012163544A1 Removal of soluble tumor necrosis factor receptor 2 (stnfr2)
12/06/2012WO2012163542A1 Vegf-d/vegfr2/3-mediated regulation of dendrites
12/06/2012WO2012163289A1 Fusion protein comprising diphtheria toxin non-toxic mutant crm197 or fragment thereof
12/06/2012WO2012162828A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
12/06/2012WO2012142159A3 Structural mutations in titin cause dilated cardiomyopathy
12/06/2012WO2012135397A3 Lactate-and ketones-induced gene signatures and use the same for diagnosing disease and predicting clinical outcome
12/06/2012WO2012106287A8 Methods of treating acute kidney injury with retinoic acid
12/06/2012WO2012106281A3 Multimodal trail molecules and uses in cellular therapies
12/06/2012WO2012098542A3 Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation-related disorders
12/06/2012WO2012061662A9 Glycomimetic-peptidomimetic inhibitors of e-selectins and cxcr4 chemokine receptors
12/06/2012WO2012051567A3 Obesity-related genes and their proteins and uses thereof
12/06/2012WO2012051207A3 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
12/06/2012WO2012012710A3 Radiation sensitization agents for prostate cancer
12/06/2012WO2011134084A8 Methods, compositions, and kits for the treatment of matrix mineralization disorders
12/06/2012WO2011131360A8 Method of determining the metastatic potential of a tumor
12/06/2012WO2011117582A9 Dendritic cell inhibitory proteins from ticks
12/06/2012US20120311728 Methods and pharmaceutical composition for the treatment of atherosclerosis
12/06/2012US20120310144 Vision through photodynamic therapy of the eye
12/06/2012US20120309938 Hemiasterlin derivatives and uses thereof in the treatment of cancer
12/06/2012US20120309936 Reducing the immunogenicity of fusion proteins
12/06/2012US20120309813 DELIVERY OF dsRNA TO ARTHROPODS
12/06/2012US20120309697 Methods of diagnosing and prognosing colonic polyps
12/06/2012US20120309696 Acth antagonist peptides
12/06/2012US20120309695 Crystalline form of linaclotide
12/06/2012US20120309694 Dual Chain Synthetic Heparin-Binding Growth Factor Analogs
12/06/2012US20120309693 Methods to Accelerate Tissue and Wound Healing Rates and Reduce Swelling and Scar Formation
12/06/2012US20120309691 Tumor targeted delivery of immunomodulators by nanopolymers
12/06/2012US20120309690 Prostaglandin-f2 alpha receptor modulators and uses thereof
12/06/2012US20120309688 Peptide substance stimulating regeneration of central nervous system neurons, pharmaceutical composition on its base, and the method of its application
12/06/2012US20120309687 Glioprotectant Peptide for Use in the Treatment of Amyotrophic Lateral Sclerosis (ALS) and Methods Related Thereto
12/06/2012US20120309686 Treatment of Rheumatoid Arthritis With Mammal Beta Defensins
12/06/2012US20120309685 Purified emd protein composition
12/06/2012US20120309684 Conjugates for delivery of biologically active compounds
12/06/2012US20120309683 USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES
12/06/2012US20120309682 Suppression of cancer metastasis
12/06/2012US20120309681 Treating or ameliorating some neuroendocrine disorders in male with help of prolactin
12/06/2012US20120309680 Functionalized oligosaccharides
12/06/2012US20120309679 Igf-i poly (ethylene glycol) conjugates
12/06/2012US20120309678 Treatment of Inflammatory Bowel Diseases With Mammal Beta Defensins
12/06/2012US20120309677 Methods for regulating blood glucose levels
12/06/2012US20120309676 Lantibiotic Salts
12/06/2012US20120309675 Peptide bfp4 for promoting osteogenesis or vascularization and use thereof
12/06/2012US20120309674 Pseudodipeptides as mmp inhibitors
12/06/2012US20120309673 Cysteine protease inhibitors
12/06/2012US20120309672 Treatment of extracellular matrix to reduce inflammation
12/06/2012US20120309671 Process for the measurement of the potency of glatiramer acetate
12/06/2012US20120309628 Bioactive agent delivery particles
12/06/2012US20120308671 Nasal ointment based on white petroleum jelly
12/06/2012US20120308661 Orally administrable pharmaceutical pellet of epidermal growth factor
12/06/2012US20120308658 Methods and compositions to treat hemorrhagic conditions of the brain
12/06/2012US20120308646 Tetracyclic anthraquinones possessing anti-cancer properties
12/06/2012US20120308645 Compositions and methods for sirna inhibition of hif-1 alpha
1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 3163